Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1970 1
1971 1
1972 3
1973 1
1975 3
1982 1
1983 1
1988 1
1989 1
1991 1
1993 3
1994 5
1995 1
1996 1
1998 1
2005 1
2008 3
2009 4
2010 1
2011 2
2013 5
2014 2
2015 5
2016 3
2017 2
2018 2
2019 1
2020 6
2021 7
2022 8
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Reward modulates cortical representations of action.
Adkins TJ, Lee TG. Adkins TJ, et al. Neuroimage. 2021 Mar;228:117708. doi: 10.1016/j.neuroimage.2020.117708. Epub 2020 Dec 30. Neuroimage. 2021. PMID: 33385555 Free article.
How well do ordinary Americans forecast the growth of COVID-19?
Fansher M, Adkins TJ, Lewis RL, Boduroglu A, Lalwani P, Quirk M, Shah P, Jonides J. Fansher M, et al. Among authors: adkins tj. Mem Cognit. 2022 Oct;50(7):1363-1380. doi: 10.3758/s13421-022-01288-0. Epub 2022 Mar 28. Mem Cognit. 2022. PMID: 35349111 Free PMC article.
The status of women and fertility.
Piepmeier KB, Adkins TS. Piepmeier KB, et al. Among authors: adkins ts. J Biosoc Sci. 1973 Oct;5(4):507-20. doi: 10.1017/s0021932000009378. J Biosoc Sci. 1973. PMID: 4585321 Review. No abstract available.
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group. Keenan TD, et al. Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27. Ophthalmology. 2018. PMID: 30060980 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
79 results